Debt-to-equity of GYRE THERAPEUTICS, INC. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
GYRE THERAPEUTICS, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • GYRE THERAPEUTICS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 30%, a 61% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

GYRE THERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 30% -46% -61% 30 Sep 2025
Q2 2025 36% -65% -64% 30 Jun 2025
Q1 2025 42% -490% -92% 31 Mar 2025
Q4 2024 47% +142% 31 Dec 2024
Q3 2024 76% +536% 30 Sep 2024
Q2 2024 101% -86% -46% 30 Jun 2024
Q1 2024 532% +508% +2124% 31 Mar 2024
Q4 2023 -95% -113% -634% 31 Dec 2023
Q3 2023 -459% -478% -2505% 30 Sep 2023
Q2 2023 187% +163% +680% 30 Jun 2023
Q1 2023 24% -5.1% -18% 31 Mar 2023
Q4 2022 18% -4.2% -19% 31 Dec 2022
Q3 2022 19% -1.8% -8.7% 30 Sep 2022
Q2 2022 24% +5% +26% 30 Jun 2022
Q1 2022 29% +12% +68% 31 Mar 2022
Q4 2021 22% +4.9% +29% 31 Dec 2021
Q3 2021 21% +0.38% +1.9% 30 Sep 2021
Q2 2021 19% -0.28% -1.5% 30 Jun 2021
Q1 2021 17% -0.8% -4.4% 31 Mar 2021
Q4 2020 17% +1.4% +9.1% 31 Dec 2020
Q3 2020 21% +13% +180% 30 Sep 2020
Q2 2020 19% +14% +288% 30 Jun 2020
Q1 2020 18% +15% +422% 31 Mar 2020
Q4 2019 16% +13% +490% 31 Dec 2019
Q3 2019 7.3% +3.3% +81% 30 Sep 2019
Q2 2019 5% -2.2% -30% 30 Jun 2019
Q1 2019 3.5% -9.9% -74% 31 Mar 2019
Q4 2018 2.6% -40% -94% 31 Dec 2018
Q3 2018 4% -62% -94% 30 Sep 2018
Q2 2018 7.1% -91% -93% 30 Jun 2018
Q1 2018 13% -128% -91% 31 Mar 2018
Q4 2017 43% -96% -69% 31 Dec 2017
Q3 2017 66% -68% -51% 30 Sep 2017
Q2 2017 98% -22% -18% 30 Jun 2017
Q1 2017 141% +772% 31 Mar 2017
Q4 2016 139% -10% -7% 31 Dec 2016
Q3 2016 134% +195% 30 Sep 2016
Q2 2016 121% +342% 30 Jun 2016
Q1 2016 -631% -639% -7919% 31 Mar 2016
Q4 2015 150% +140% +1415% 31 Dec 2015
Q3 2015 -61% -70% -724% 30 Sep 2015
Q2 2015 -221% -233% -2055% 30 Jun 2015
Q1 2015 8.1% -2.4% -23% 31 Mar 2015
Q4 2014 9.9% +0.9% +10% 31 Dec 2014
Q3 2014 9.7% -1.7% -15% 30 Sep 2014
Q2 2014 11% +0.69% +6.5% 30 Jun 2014
Q1 2014 10% -0.81% -7.2% 31 Mar 2014
Q4 2013 9% -11% -55% 31 Dec 2013
Q3 2013 11% -11% -49% 30 Sep 2013
Q2 2013 11% -24% -69% 30 Jun 2013
Q1 2013 11% -36% -76% 31 Mar 2013
Q4 2012 20% 31 Dec 2012
Q3 2012 22% 30 Sep 2012
Q2 2012 34% 30 Jun 2012
Q1 2012 48% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.